Trial intelligence / Profile preview

Bioequivalence study of duloxetine 60 mg vs Cymbalta in healthy Thai volunteers under fasting conditions

TCTR20240701004Phase 1Unknown

Sponsor
International Bio Service
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of duloxetine (2 arms), sponsored by International Bio Service. Status: unknown.

02

Drugs

duloxetine

Beyond the preview

Go deeper on TCTR20240701004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240701004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call